Is Schering‘s contraceptive NuvaRing dangerous.? This article raises the question. My take – it’s always a yellow light for me when I see a journalistic heart-string approach based on an isolated (and unproven) incident. What sells newspapers is not the same as science.
Does this really need to be treated as a “new drug”? I have some real problems with this approach – AstraZeneca files NDA for Nexium + low-dose aspirin. Umm, folks, this is not a scientific advance. And patients are fully able to take an aspirin without needing an expensive purple coating over it…
BusinessWeek gives its list of the 10 most promising new drugs (due out over next 2 years). Fairly interesting if you’ve not been keeping up with pipelines – not much new information here, however.
Subscribe to the Impactiviti blog via e-mail
Subscribe to the Impactiviti blog via RSS
Connect with Steve Woodruff